more_reports

The Latest Healthcare Services Articles from Streetwise Reports

Virtual Care Network Expands to Include 100,000 More New Yorkers, Reaching 24 Million Nationwide

  ()
Rocket Doctor AI Inc. (AIDR:CSE; AIRDF:OTC; 939:FRA) recently added 100,000 eligible members in New York to its network. This expansion brings the total number of individuals with potential in-network access to the company's virtual care services to approximately 10 million in New York and 24 million across the United States.
Tags: Biotechnology / PharmaceuticalsHealthcare Services

Virtual Care AI Provider Expands Potential Access to 100k+ New York Covered Lives

  ()
Rocket Doctor AI expanded potential in-network access to more than 100,000 additional eligible covered lives in New York through a new payer agreement, while continuing to expand its physician network and healthcare AI capabilities in the United States.
Tags: Biotechnology / PharmaceuticalsHealthcare ServicesArtificial Intelligence

AI Health Platform Expands Into Women's Health and Sleep With New Revenue Expected in Q4

  ()
DarioHealth Corp. (DRIO:NASDAQ) launched Dario Women and Dario Sleep, expanding its provider-backed cardiometabolic platform with programs expected to begin contributing recurring revenue in the fourth quarter.
Tags: Healthcare Services

Digital Health Provider Launches Women's Health and Sleep Solutions

  ()
DarioHealth expands its cardiometabolic platform with Dario Women and Dario Sleep programs. Revenue contribution expected late 2026 amid rising demand for multi-condition digital care solutions.
Tags: Healthcare Services

This AI Healthcare Platform Is Taking Its New York Expansion Through 2029

  ()
Rocket Doctor AI Inc. (AIDR:CSE; AIRDF:OTC; 939:FRA) extended its EngageWell partnership after an initial virtual-care pilot connected more than 400 underserved New Yorkers with physician-led care.
Tags: Healthcare ServicesLife Sciences Tools & DiagnosticsArtificial IntelligenceTechnology

NY Telehealth Extension Advances Rocket Doctor AI Platform

  ()
Rocket Doctor AI extends its New York telehealth engagement through 2029, combining grants and Medicaid to serve underserved patients while scaling its AI platform amid strong digital health market growth.
Tags: Healthcare ServicesLife Sciences Tools & DiagnosticsArtificial IntelligenceTechnology

New GLP-1 Platform Combines Doctor Prescriptions, AI Coaching and Chronic Care

  ()
DarioHealth Corp. (NASDAQ: DRIO) introduced its Integrated GLP-1 Program, bringing licensed provider evaluations, FDA-approved GLP-1 prescribing where clinically appropriate and ongoing care into one experience.
Tags: Biotechnology / PharmaceuticalsHealthcare Services

Digital Health Firm Launches Integrated GLP-1 Program

  ()
DarioHealth integrates its digital platform with licensed providers to offer end-to-end GLP-1 support. See how the new program targets employers and health plans in a growing market.
Tags: Biotechnology / PharmaceuticalsHealthcare Services

Healthcare Platform Clears Major Security Milestone After Independent Audit

  ()
Rocket Doctor AI Inc. (AIDR:CSE; AIRDF:OTC; 939:FRA) said its wholly owned Rocket Doctor platform achieved SOC 2 Type I compliance following an independent third-party audit of its security, privacy, and operational controls.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

Digital Health Platform Achieves SOC 2 Milestone in Booming Sector

  ()
Rocket Doctor AI reaches SOC 2 Type I compliance, strengthening its enterprise position as the digital health market expands rapidly with rising AI adoption.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

Cleantech Co. Relaunches Pet Brand Under Its Own Control

  ()
BioLargo Inc. (BLGO:OTCQX) unveils plans to reintroduce its enormously popular CupriDyne-based pet odor products to the consumer market. This time, the company says it will own the brand and do it its own way.
Tags: TechnologySpecial SituationsHealthcare ServicesLife Sciences Tools & DiagnosticsCleantech

Pet Odor Market Ignites BioLargo Consumer Comeback

  ()
BioLargo re-enters the booming U.S. pet odor control market with a direct-to-consumer CupriDyne brand, building on proven demand while advancing water treatment and medical technologies for retail investors.
Tags: TechnologySpecial SituationsHealthcare ServicesLife Sciences Tools & DiagnosticsCleantech

AI Engine Delivers Engagement Gains as Recurring Revenue Outlook Climbs

  ()
DarioHealth Corp. (DRIO:NASDAQ) said its DarioIQ platform reflects the ongoing digital health rotation and AI transformation across healthcare, with broader deployment expected to increase recurring revenue from existing customers by 10% to 15%.
Tags: Life Sciences Tools & DiagnosticsHealthcare ServicesTechnologyArtificial Intelligence

DarioHealth AI Platform Targets 10-15% Revenue Growth from Existing Clients

  ()
DarioHealth's DarioIQ AI engine is positioned to lift B2B2C recurring revenue 10-15% from current customers while the AI healthcare market expands rapidly toward hundreds of billions.
Tags: TechnologyHealthcare ServicesLife Sciences Tools & DiagnosticsArtificial Intelligence

Digital Health Platform Lands Access to Hundreds of Thousands of Covered Lives

  ()
DarioHealth Corp. (DRIO:NASDAQ) signed a new agreement through its Amwell partnership that makes its cardiometabolic platform available to a major Arizona health insurer's ASO business, representing hundreds of thousands of covered lives.
Tags: Healthcare Services

First-of-Its-Kind US Brain Imaging Clinic Takes Delivery of Key PET Scanner

  ()
Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) received its first brain-dedicated PET scanning system for its flagship Florida NovaScan Neuroimaging Clinic, which the company said will be the first U.S. facility dedicated to brain-only PET imaging for Alzheimer's disease and other neurological conditions.
Tags: Life Sciences Tools & DiagnosticsHealthcare Services

Grey Matters Health Inc. Targets Alzheimer's PET Imaging Opportunity

  ()
Grey Matters Health Inc. advances first U.S. brain-dedicated PET clinic for Alzheimer's detection amid surging diagnostics demand. Learn the key facts for investors.
Tags: Life Sciences Tools & DiagnosticsHealthcare Services

Digital Health Pioneer Targets Massive Breakthrough Chronic Care Market

  ()
AI-driven digital health solutions pioneer DarioHealth Corp. (DRIO:NASDAQ) announces a partnership that it says will give it access to a network spanning all 50 states. Find out why analysts like the direction the company is taking.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

DarioHealth (DRIO) Expands Reach via Beluga Health Deal

  ()
DarioHealth (DRIO) integrates its AI platform with Beluga Health's network to scale provider-backed care. Discover growth catalysts, analyst targets, and investor considerations.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

Grey Matters Health Inc. Advances US Alzheimer's Clinics

  ()
Grey Matters Health Inc. closes CA$1.25M financing to launch brain-specific PET clinics targeting the expanding Alzheimer's diagnostics market and early detection demand.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

DarioHealth: Chronic Care Platform Drives Value

  ()
DarioHealth targets the booming digital health market with a multi-condition platform backed by 27 ADA studies. See pipeline growth, analyst targets, and key catalysts for investors.
Tags: Healthcare ServicesArtificial IntelligenceTechnologyMedical Devices

Alzheimer's Imaging Push Gains Fresh Funding as U.S. Clinic Plans Move Forward

  ()
Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) closed an expanded US$1.25 million private placement and said proceeds will support its Alzheimer's disease program and planned first U.S. brain-specific neuroimaging clinic.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

Four New ADA Studies Reveal Clinical Wins in Weight, Blood Sugar, and Healthcare Utilization

  ()
DarioHealth Corp. (DRIO:NASDAQ) presented four studies at the ADA Scientific Sessions reporting weight loss of up to 14.3%, fewer hospitalizations, and improved glycemic outcomes among high-risk cardiometabolic users of its digital health platform.
Tags: Healthcare ServicesArtificial IntelligenceTechnologyMedical Devices

Grey Matters Health Positions for Growth in Expanding Alzheimer's Diagnostics Market

  ()
Grey Matters Health advances its Alzheimer's neuroimaging strategy with fresh financing and plans for the first U.S. brain-specific PET clinic, capitalizing on rising demand for early detection tools.
Tags: Life Sciences Tools & DiagnosticsHealthcare Services

Alzheimer's Diagnostic Clinic Initiative Moves Forward After Financing Close

  ()
Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) closed the first CA$500,000 tranche of a financing that the company said will support its Alzheimer's disease program and planned U.S. brain-specific neuroimaging clinic.
Tags: Life Sciences Tools & DiagnosticsHealthcare Services

Showing Results: 1 to 25 of 33 Next